P-31 SHORT-TERM EFFICACY AND SAFETY OF LOLA THERAPY IN PATIENTS WITH CIRRHOSIS AND MINIMAL HEPATIC ENCEPHALOPATHY: A REAL-LIFE COHORT STUDY Fátima Higuera-De La Tijera; AB Moreno-Cobos; Christian Hinojosa-Segura; Diana Montemira-Orozco; Imran Cruz-Reyes; Juana Zavala-Ramírez; Daniel Santana-Vargas; Alfredo Servín-Caamaño; Juan Miguel Abdo-Francis; José Luis Pérez-Hernández;

LILLE-4 vs. LILLE-7 to predict short-term mortality in patients with severe alcoholic hepatitis Claudia L. Dorantes-Nava; María F. Higuera-de la Tijera; Alfredo Servín-Caamaño; Gabriela Gutiérrez-Reyes; Miguel Y. Carmona-Castillo; Sandra Teutli-Carrion; Ernesto J. Medina-Avalos; José L. Pérez-Hernández;

MELD Na and MELD 3.0 have the best performance in predicting the risk of death at 28 days in patients with severe alcoholic hepatitis in the Mexican population CL Dorantes-Nava; F Higuera-de la Tijera; A Servín-Caamaño; F Salas-Gordillo; JM Abdo-Francis; G Gutiérrez-Reyes; P Diego-Salazar; MY Carmona-Castillo; S Teutli- Carrion; EJ Medina ¿Avalos; A Servín-Higuera; JL Pérez-Hernández;